What is the share price of Park Medi World Ltd (PARKHOSPS) today?
The share price of PARKHOSPS as on 24th July 2026 is ₹280.25. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Park Medi World Ltd (PARKHOSPS) share?
The past returns of Park Medi World Ltd (PARKHOSPS) share are- Past 1 week: -3.04%
- Past 1 month: -1.86%
- Past 3 months: 20.43%
- Past 6 months: 84.35%
- Past 1 year: 89.42%
- Past 3 years: N/A%
- Past 5 years: 89.42%
What are the peers or stocks similar to Park Medi World Ltd (PARKHOSPS)?
The peers or stocks similar to Park Medi World Ltd (PARKHOSPS) include:What is the market cap of Park Medi World Ltd (PARKHOSPS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Park Medi World Ltd (PARKHOSPS) is ₹12104.86 Cr as of 24th July 2026.What is the 52 week high and low of Park Medi World Ltd (PARKHOSPS) share?
The 52-week high of Park Medi World Ltd (PARKHOSPS) is ₹305 and the 52-week low is ₹138.10.What is the PE and PB ratio of Park Medi World Ltd (PARKHOSPS) stock?
The P/E (price-to-earnings) ratio of Park Medi World Ltd (PARKHOSPS) is 46.90. The P/B (price-to-book) ratio is 10.75.Which sector does Park Medi World Ltd (PARKHOSPS) belong to?
Park Medi World Ltd (PARKHOSPS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Park Medi World Ltd (PARKHOSPS) shares?
You can directly buy Park Medi World Ltd (PARKHOSPS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Park Medi World Ltd
PARKHOSPS Share Price
NSE₹280.251.25% (-3.55)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
PARKHOSPS Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
PARKHOSPS Performance & Key Metrics
PARKHOSPS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 47.73 | 10.75 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.74 | 5.90 | 0.53% |
100%
Analysts have suggested that investors can buy this stock
from 2 analysts
Price Upside
Earnings Growth
Rev. Growth
PARKHOSPS Company Profile
Park Medi World Ltd operates a chain of over 13 NABH-accredited multi-specialty hospitals in North India, offering more than 30 super specialty and specialty medical services including cardiology, neurology, urology, gastroenterology, oncology, and various surgical disciplines.
APOLLOHOSP
PE Ratio
65.21
65.21
1Y Return
19.58%
19.58%
Buy Reco %
86.67
86.67
MAXHEALTH
PE Ratio
72.90
72.90
1Y Return
14.75%
14.75%
Buy Reco %
83.33
83.33
FORTIS
PE Ratio
68.75
68.75
1Y Return
12.07%
12.07%
Buy Reco %
85.00
85.00
ASTERDM
PE Ratio
176.44
176.44
1Y Return
32.03%
32.03%
Buy Reco %
100.00
100.00
PE Ratio
79.18
79.18
1Y Return
0.96%
0.96%
Buy Reco %
85.71
85.71
PARKHOSPS Sentiment Analysis
PARKHOSPS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
PARKHOSPS Stock Summary · May 2026
Strong results were the dominant message, with management reporting FY'26 revenue of INR 1,679 crore and EBITDA of INR 444 crore as records for the year and quarter. Management emphasized aggressive but disciplined expansion—adding a largest‑ever 610 beds in FY'26 and growing the network to its biggest footprint—while prioritizing balance‑sheet strength, cash generation and payor mix upgrades to drive ARPOB and margins. They highlighted a deliberate mix of fast‑accreting brownfield acquisitions, which contributed a majority of revenue and often reach profitability quickly, versus capital‑intensive greenfield projects that typically achieve EBITDA positivity early but take multiple years to fully recover revenue and carry recurring staffing costs initially. Management also underlined material liquidity improvement and a receivables provisioning item near INR 200 crore, noting collections have improved but remain tied to government billing cycles. Near term they reaffirmed a capex plan to add ~1,500 beds by March 2028 (c. INR 500 crore of investment, funded from strong cash balances and limited incremental debt), and expect CGHS tariff benefits to phase in after Q1 FY27.
PARKHOSPS Stock Growth Drivers
PARKHOSPS Stock Growth Drivers
6Record Financial Performance and Margin Expansion
Park Medi World delivered its strongest financial year on record in FY26 with consolidated revenue
Capital‑Efficient Network Expansion with a Committed Bed Pipeline
The company executed its largest single‑year capacity addition in FY26 by adding 610 beds (over
PARKHOSPS Stock Challenges
PARKHOSPS Stock Challenges
5Receivables concentration, slow collections and elevated provisioning
The company faces material receivables and working-capital stress: receivables ran at roughly 129 debtor days
Margin compression from subsidised oncology pricing and rising input costs
Profitability is under pressure from both deliberate low-priced supply arrangements and rising operating costs. Management
PARKHOSPS Forecast
PARKHOSPS Forecasts
Price
Revenue
Earnings
PARKHOSPS Share Price Forecast
PARKHOSPS Share Price Forecast
2026
Current
₹280.25
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹280.25
Baseline
Forecast for Jul 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
PARKHOSPS Company Revenue Forecast
PARKHOSPS Company Revenue Forecast
2026
Current
₹1.71
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
2026
Current
₹1.71
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ Thousand cr.
PARKHOSPS Stock EPS (Earnings Per Share) Forecast
PARKHOSPS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹6.87
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹6.87
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
PARKHOSPS
PARKHOSPS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
PARKHOSPS Income Statement
PARKHOSPS Income Statement
Quarterly Normal View
| Quarter | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 362.89 | 362.49 | 405.16 | 418.23 | 419.07 | 467.92 | ||||||
Operating & Other expenses | 265.32 | 265.49 | 294.06 | 297.46 | 310.56 | 333.05 | ||||||
EBITDA | 97.57 | 97.00 | 111.10 | 120.77 | 108.51 | 134.87 | ||||||
| Depreciation/Amortization | 15.03 | 15.53 | 13.43 | 14.89 | 15.30 | 17.51 | ||||||
| PBIT | 82.54 | 81.47 | 97.67 | 105.88 | 93.21 | 117.36 | ||||||
| Interest & Other Items | 15.73 | 15.65 | 15.13 | 14.53 | 14.95 | 13.98 | ||||||
| PBT | 66.81 | 65.82 | 82.54 | 91.35 | 78.26 | 103.38 | ||||||
| Taxes & Other Items | 21.22 | 21.00 | 24.09 | 17.79 | 27.52 | 32.53 | ||||||
| Net Income | 45.59 | 44.82 | 58.45 | 73.56 | 50.74 | 70.85 | ||||||
| EPS | 1.19 | 1.36 | 1.52 | 2.04 | 1.35 | 1.78 |
PARKHOSPS Company Updates
FY 2026FY 2026
Investor Presentation
May 12PDF
Jan 28PDF
Jan 28PDF
PARKHOSPS Stock Peers
PARKHOSPS Past Performance & Peer Comparison
PARKHOSPS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Park Medi World Ltd | 46.90 | 10.75 | — |
| Apollo Hospitals Enterprise Ltd | 65.21 | 11.41 | 0.23% |
| Max Healthcare Institute Ltd | 72.90 | 9.78 | 0.19% |
| Fortis Healthcare Ltd | 68.75 | 7.04 | 0.11% |
PARKHOSPS Stock Price Comparison
Compare PARKHOSPS with any stock or ETFCompare PARKHOSPS with any stock or ETF
PARKHOSPS
PARKHOSPS Holdings
PARKHOSPS Shareholdings
PARKHOSPS Promoter Holdings Trend
PARKHOSPS Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
PARKHOSPS Institutional Holdings Trend
PARKHOSPS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
PARKHOSPS Shareholding Pattern
PARKHOSPS Shareholding Pattern
PARKHOSPS Shareholding History
PARKHOSPS Shareholding History
Foreign Institutions
Mutual Funds Invested in PARKHOSPS
Mutual Funds Invested in PARKHOSPS
No mutual funds holding trends are available
Top 5 Mutual Funds holding Park Medi World Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 2.2422% | Percentage of the fund’s portfolio invested in the stock 1.90% | Change in the portfolio weight of the stock over the last 3 months 0.47% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 56/105 (+3) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0501% | Percentage of the fund’s portfolio invested in the stock 2.38% | Change in the portfolio weight of the stock over the last 3 months 0.66% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 10/70 (+28) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6429% | Percentage of the fund’s portfolio invested in the stock 1.26% | Change in the portfolio weight of the stock over the last 3 months 0.48% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 40/60 (+2) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing PARKHOSPS stock
smallcases containing PARKHOSPS stock
Looks like this stock is not in any smallcase yet.
PARKHOSPS Events
PARKHOSPS Events
PARKHOSPS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PARKHOSPS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
PARKHOSPS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
PARKHOSPS has not given any dividends in last 5 years
PARKHOSPS Dividends
PARKHOSPS Dividends
Hmm, looks like data is unavailable here. Please come back after some timePARKHOSPS Stock News & Opinions
PARKHOSPS Stock News & Opinions
Articles & Videos
Corporate
Corporate
Park Medi World announces 100-bed expansion at its Palam Vihar facilityUmkal Health Care, a wholly-owned subsidiary of Park Medi World, has today approved a significant expansion of its existing 225-bed Park Hospital in Palam Vihar, Gurugram, with the addition of 100 new beds. The Palam Vihar facility is one of the flagship hospitals of the group; in FY'26, it had an occupancy of ~86%, delivered a revenue of ~Rs 245 crore. The newly expanded facility will be branded Park Hospital Platinum and is slated to commence operations in November 2026. With this expansion, Park Group's consolidated bed capacity across Gurugram will rise to 750 beds.
3 weeks agoCapital Market - Live
Spotlight
Spotlight
Park Medi World gallops on acquisition of Medicity HospitalThe acquisition will be carried out through the purchase of V3 Healthcare, which operates The Medicity Hospital. The transaction will be completed in two phases, with 80% stake acquisition expected by 31 August 2026 and the remaining 20% by 30 April 2030. The Medicity Hospital is a 330-bed multi-super speciality hospital and is the largest hospital in the Kumaon region. The facility is NABH accredited and offers more than 20 specialities, including cardiology, neurosurgery, oncology, orthopaedics and nephrology. Park Medi World said the acquisition marks its entry into Uttarakhand and expands its presence to a sixth state. The company said the deal aligns with its strategy of expanding in high-potential and underserved healthcare markets. The target company reported unaudited turnover of Rs 55.74 crore in FY26 compared with Rs 49.04 crore in FY25 and Rs 42.46 crore in FY24. Park Group currently operates 16 hospitals with a combined capacity of 3,960 beds across North India. The group plans to add another 1,500 beds through ongoing expansion projects, taking total capacity to 5,790 beds by March 2028. On a consolidated basis, Park Medi World's net profit rose 58.03% to Rs 70.86 crore while net sales rose 30.09% to Rs 460.41 crore in Q4 March 2026 over Q4 March 2025. Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Earnings
Park Medi World consolidated net profit rises 58.03% in the March 2026 quarterNet profit of Park Medi World rose 58.03% to Rs 70.86 crore in the quarter ended March 2026 as against Rs 44.84 crore during the previous quarter ended March 2025. Sales rose 30.09% to Rs 460.41 crore in the quarter ended March 2026 as against Rs 353.92 crore during the previous quarter ended March 2025. For the full year,net profit rose 28.01% to Rs 258.12 crore in the year ended March 2026 as against Rs 201.64 crore during the previous year ended March 2025. Sales rose 20.51% to Rs 1679.36 crore in the year ended March 2026 as against Rs 1393.57 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales460.41353.92 30 1679.361393.57 21 OPM %27.6624.99 -26.4626.62 - PBDT120.9081.36 49 417.05342.57 22 PBT103.3965.83 57 354.58285.67 24 NP70.8644.84 58 258.12201.64 28 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Park Medi World to table resultsPark Medi World will hold a meeting of the Board of Directors of the Company on 12 May 2026.
2 months agoCapital Market - Live
Spotlight
Spotlight
Park Medi World rises after launching Panchkula hospitalThe newly launched facility is aimed at strengthening access to tertiary and quaternary care across the Tricity region, covering Haryana, Punjab, Himachal Pradesh, and Chandigarh. The move is expected to reduce dependence on metro cities such as Delhi for advanced treatments. The Panchkula hospital is equipped with advanced diagnostics, modular operation theatres, and critical care infrastructure. It will offer services across major specialties including oncology, neurosciences, orthopedics, cardiology, and robotic-assisted procedures, with a significant focus on high-acuity and critical care. The launch comes alongside the ongoing expansion of the company's Mohali facility, further scaling its regional presence. With this, the group's combined capacity in the Tricity region is expected to reach around 850 beds. Park Group currently operates 16 hospitals with a total capacity of 3,960 beds. The company is also in the process of adding five more hospitals and expanding existing facilities, which is expected to increase total capacity to 5,460 beds by March 2028. On a consolidated basis, net profit of Park Medi World rose 11.38% to Rs 50.78 while net sales rose 17.76% to Rs 409.97 crore in Q3 December 2025 over Q3 December 2024.
3 months agoCapital Market - Live
Corporate
Corporate
Park Medi World launches multi-specialty hospital in PanchkulaPark Group of Hospitals has today launched advanced multi-super specialty hospital in Panchkula, alongside the ongoing expansion of its Mohali facility, strengthening access to advanced healthcare across the Tricity region. The hospital has been developed to address the growing demand for tertiary and quaternary care services across Haryana, Punjab, Himachal Pradesh, and Chandigarh. By bringing high-end medical care closer to patients, the hospital aims to reduce dependence on metro cities such as Delhi for advanced treatments. The Panchkula hospital is equipped with advanced diagnostics, modular operation theatres, critical care infrastructure, and will deliver comprehensive care across key specialties including oncology, neurosciences, orthopedics, cardiology, and critical care including robotic-assisted procedures. Designed with a strong focus on high-acuity care, a significant proportion of beds are dedicated to critical care services.
3 months agoCapital Market - Live
Corporate
Corporate
Park Medi World to launch Panchkula Hospital on 10 AprilPark Medi World set to launch Panchkula Hospital on 10 April 2026 instead of previously announced 29 March 2026. Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Corporate
Park Medi World board approves launch of Panchkula hospital and expansion of Mohali hospitalThe board of Park Medi World at its meeting held on 10 March 2026 has approved the launch of a multispecialty hospital at Panchkula on 29 March 2026. The board also approved the addition of bed capacity y of Grecian Super Speciality Hospital, Mohali (Mohali Hospital) by adding 150 beds to the existing bed capacity of 350 beds. The Mohali Hospital is run and operated by RGS Healthcare, subsidiary of the company. Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
Park Medi World consolidated net profit rises 11.38% in the December 2025 quarterNet profit of Park Medi World rose 11.38% to Rs 50.78 crore in the quarter ended December 2025 as against Rs 45.59 crore during the previous quarter ended December 2024. Sales rose 17.76% to Rs 409.97 crore in the quarter ended December 2025 as against Rs 348.13 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales409.97348.13 18 OPM %24.2523.78 - PBDT93.5781.83 14 PBT78.2766.81 17 NP50.7845.59 11 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Park Medi World to table resultsPark Medi World will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live
6 months agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 17.33%, vs industry avg of 15.81%
Over the last 5 years, market share increased from 1.87% to 1.94%
Over the last 5 years, net income has grown at a yearly rate of 10.77%, vs industry avg of 55.89%